Prokaryotics
Dr. Bonomo is Distinguished University Professor of Medicine, Pharmacology, Molecular Biology and Microbiology at Case Western Reserve University and Director of the Case VA Center for Antimicrobial Resistance and Epidemiology. He brings 30+ years of experience in clinical medicine and the study of how Gram-negative bacteria evolve multidrug-resistance.
This person is not in the org chart
This person is not in any offices
Prokaryotics
Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria.